Table 1. Case description and tumorigenic activity of CD49fhigh and CD49flow tumor cells.
| Patientnumber | Age/sex | Site | Bormann type | Differentiationof tumors | PDTX lines | Ratio of CD49highcells (%) | Number of cells injected (number oftumors/number of injection) | Differentiation of tumors formed by sorted cells | |
| CD49fhigh | CD49flow | ||||||||
| 1 | 80/M | Fundic | II | Moderate | HGC-1 | 2.7 | 3,000 (1/1) | 6,000 (0/1) | Moderate |
| 2 | 75/M | Fundic | III | Well | HGC-2 | 6.5 | 3,000 (3/3) | 3,000 (1/2) | Well |
| 3 | 72/M | Pyloric | IV | Poor | HGC-3 | 16.4 | 3,000 (1/1) | 3,000 (0/2) | Poor |
| 4 | 71/M | Fundic | II | Moderate | HGC-4 | 6.2 | 3,000 (1/1) | 3,000 (0/1) | Moderate |
| 5 | 68/F | Pyloric | II | Poor | HGC-5 | 10.8 | 3,000 (3/3) | 3,000 (1/4) | Poor |
| 6 | 66/M | Pyloric | II | Moderate | 14.8 | 3,000 (1/1) | 3,000 (0/1) | Moderate | |
| 7 | 74/M | Antrum | III | Poor | 20.8 | 3,000 (1/1) | 3,000 (1/1) | Poor | |
| 8 | 64/M | Antrum | II | Moderate | 8.8 | 3,000 (1/2) | 3,000 (0/1) | Moderate | |
| 9 | 40/M | Fundic | III | Poor | 5.3 | 3,000 (1/1) | 3,000 (0/1) | Poor | |
| 10 | 72/M | Antrum | III | Poor | 3.0 | 1,000 (1/1)3,000 (1/1) | 1,000 (0/1)3,000 (0/1) | Poor | |
| 11 | 70/M | Fundic | II | Moderate | 10.9 | 3,000 (1/1) | 3,000 (0/1) | Moderate | |
| 12 | 68/M | Antrum | III | Poor | 1.1 | 3,000 (1/1) | 3,000 (0/1) | Poor | |
| 13 | 68/M | Antrum | II | Poor | 1.6 | 3,000 (1/2) | 3,000 (0/2) | Poor | |
| 14 | 76/F | Pyloric | III | Poor | 2.8 | 3,000 (2/2) | 3,000 (0/2) | Poor | |
| 15 | 71/M | Pyloric | III | Moderate | 5.5 | 3,000 (1/2) | 3,000 (0/2) | Moderate | |
| Total | 5 | 7.9±6.1 | 3,000 (20/23)*** | 3,000 (3/22)*** | |||||
***
P<0.001 by Chi-square test.